NCT01634620View on ClinicalTrials.gov

Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DEVICE

NIOX MINO® Instrument (09-1100)

"FeNO measurements will be performed according to the Perform FeNO Measurement guidelines on page 7 of the NIOX MINO® User Manual (February, 2011)"

Trial Locations (2)

27330

University of North Carolina Hospitals - Sanford Specialty Clinics, Sanford

27599

University of North Carolina Hospitals, Chapel Hill

Sponsors

Lead Sponsor

Aerocrine AB
All Listed Sponsors
lead

Aerocrine AB

INDUSTRY

NCT01634620 - Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease | Biotech Hunter | Biotech Hunter